Justin M Yeung
Overview
Explore the profile of Justin M Yeung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lotter J, Zhao K, Rouse M, Faragher I, Yeung J
ANZ J Surg
. 2025 Mar;
PMID: 40040504
No abstract available.
2.
Karanatsios B, Prang K, Yeung J, Gibbs P
Trials
. 2024 Dec;
25(1):834.
PMID: 39696640
Background: Traditional randomised controlled trials (RCTs) are the gold standard for evaluating the effectiveness of interventions in clinical research. Traditional RCTs however are complex, expensive and have low external validity....
3.
Wei M, Hong W, Cao K, Loft M, Gibbs P, Yeung J
ANZ J Surg
. 2024 Nov;
95(1-2):163-168.
PMID: 39601410
Introduction: Patient body composition (BC) has been shown to help predict clinical outcomes in rectal cancer patients. Artificial intelligence algorithms have allowed for easier acquisition of BC measurements, creating a...
4.
Kim G, Jalali A, Gard G, Yeung J, Chau H, Gately L, et al.
Clin Colorectal Cancer
. 2024 Nov;
24(1):72-81.
PMID: 39523153
Background: Surgery improves long-term survival for resectable, liver-only metastatic colorectal cancer (mCRC). With no consensus definition of "resectable" disease, decisions regarding resectability are reliant on the expertise and judgement of...
5.
Rafiq M, Drosdowsky A, Solomon B, Alexander M, Gibbs P, Wright G, et al.
Cancer Med
. 2024 Jul;
13(14):e70006.
PMID: 39001673
Introduction: Abnormal results in common blood tests may occur several months before lung cancer (LC) and colorectal cancer (CRC) diagnosis. Identifying early blood markers of cancer and distinct blood test...
6.
Wei M, Yeung J, Faragher I
ANZ J Surg
. 2024 Jun;
94(10):1681-1682.
PMID: 38874278
No abstract available.
7.
Wei M, Cao K, Hong W, Yeung J, Lee M, Gibbs P, et al.
ANZ J Surg
. 2024 Mar;
94(7-8):1286-1291.
PMID: 38456517
Background: The treatment of locally advanced rectal cancer (LARC) is moving towards total neoadjuvant therapy and potential organ preservation. Of particular interest are predictors of pathological complete response (pCR) that...
8.
Piercey O, Wong H, Leung C, To Y, Heong V, Lee M, et al.
Clin Colorectal Cancer
. 2024 Jan;
23(1):95-103.e3.
PMID: 38242766
Background: A substantial proportion of patients with stage III colorectal cancer (CRC) are older than 70 years. Optimal adjuvant chemotherapy (AC) for older patients (OP) continues to be debated, with...
9.
Gartrell R, Qiao J, Kiss N, Faragher I, Chan S, Baird P, et al.
ANZ J Surg
. 2023 May;
93(9):2166-2171.
PMID: 37209307
Background: There is mounting evidence that suggests sarcopenia can be used to predict survival outcomes in patients with colon cancer. However, the effect on locally advanced rectal cancer (LARC) is...
10.
Wei M, Arafat Y, Lee M, Kosmider S, Loft M, Faragher I, et al.
ANZ J Surg
. 2023 Jan;
93(10):2285-2286.
PMID: 36716258
No abstract available.